Comparison
Semax vs Selank
A neutral structural reference comparing Semax and Selank by classification, peptide structure and physical format.
Semax vs Selank
This page compares the compounds as materials: what class each belongs to, what the molecule looks like, and how each is supplied. It is a structural and analytical reference — it makes no efficacy claims and contains no protocols.
Side-by-side profile
| Property | Semax | Selank |
|---|---|---|
| Classification | ACTH(4-10) analog nootropic peptide | tuftsin analog heptapeptide |
| Other designations | — | — |
| Molecular weight | See lot COA | See lot COA |
| Reported half-life | — | — |
| Supplied vial sizes | 30 mg vial / 50 mg nasal | 10 mg vial / 40 mg nasal |
| Purity specification | ≥99% HPLC | ≥99% HPLC |
| Research focus | BDNF and cognitive-model research | anxiolytic-pathway and GABA research |
Reading the comparison
Receptor classification is the meaningful difference between these compounds; vial size and purity specification are supply characteristics, not properties of the molecule. Where molecular weights differ substantially, expect different reconstitution arithmetic for the same nominal vial mass — run each through the peptide calculator.
Individual references
- Semax
- Selank
Documentation supplied by PX1 Research
Every PX1 lot ships with HPLC purity, LC-MS identity confirmation, residual solvent, moisture (Karl Fischer), sterility and endotoxin data. Lot records are published at /coa and /endotoxin-reports. Synthesis, purification, lyophilization and vial fill are performed in U.S. facilities — see /manufacturing-process.
Research use only. PX1 Research supplies compounds for laboratory and in-vitro research. Nothing on this page is medical advice, a dosing recommendation, or an offer for human or veterinary use.